Grant: Discovery Grants Program - Individual
University of Victoria
$48,000.00
Mechanisms of nanotechnology mediated radiosensitization with megavoltage and kilovoltage photons in vitro using two-and three-dimensional cell models
FY 2024-25
Summary
Radiotherapy is one of the main modalities investigated in cancer research. It has been shown that the incorporation of radiosensitizing agents into cancer cells can further enhance the radiation dose. This has resulted in an increase in tumor cell killing. Our previous work showed that gold nanoparticles (GNPs) can be used as a radiosensitizing agent. Radiation consists of photons, and these photons can produce a shower of secondary electrons in the presence of GNPs since gold has a high atomic number. These secondary electrons can interact with water molecules (which is over 70% in our cell) and produce free radicals that can damage DNA, which could lead to cell death. In this proposed program, we are testing a combination of two radiosensitizing agents, paclitaxel and GNPs. This combination is unique since radiosensitizing agent paclitaxel can block the cell cycle in a phase (G2/M), which is most sensitive to radiation, and GNPs can act as a physical radiosensitizing agent.
We will investigate the radiation dose enhancement in cancer cells when the agents are simultaneously co-delivered versus co-incubated using both lower (keV) and higher (MeV) energy photons. For co-delivery of agents, we will use GNPs as a carrier for paclitaxel. GNPs are being used as drug delivery vehicles because of their biocompatibility and easiness in conjugating other molecules onto its surface. We will use two- and three-dimensional monoculture and co-culture models to investigate the uptake and transport of GNPs in the presence of paclitaxel to determine the optimum time point for delivery of radiation dose. Once we know the optimum time point, we will deliver radiation doses from 2 to 10 Gy with a linear accelerator (MeV photons) and an IR-192 (keV photons) source. We will evaluate the radiation dose enhancement via cell proliferation assay, clonogenic assay, and DNA double strand breaks assay. We will then perform Monte Carlo Simulations to model our experimental data to further understand the mechanisms of radiosensitization.
We will also engineer co-culture models (vs monoculture with one cell type) since they would have features of a real tumor microenvironment with other cell components. For example, cancer associated fibroblast cells (CAFs) promote cancer cell growth, and we want to investigate whether our proposed technology (GNPs, PTX, and radiation) silences those CAFs in a way that they cannot promote cancer cell growth. Such outcomes are critical in bringing this technology to clinic in the future. Our proposed technology and these models together will also pave the way for better cancer therapeutics in the future.
This proposed research program will a) provide a better strategy to enhance radiosensitization, b) provide a full understanding behind the mechanisms of actions using experiments and theory, and c) engineer better 2D and 3D models for testing novel therapeutics.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05967
Name nom
Chithrani, Devika
Department département
Physics and Astronomy
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
48000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Mechanisms of nanotechnology mediated radiosensitization with megavoltage and kilovoltage photons in vitro using two-and three-dimensional cell models
Keywords
radiosensitizing agents; imaging; nanotechnology; monte carlo simulations; anticancer drugs; gold nanoparticles; two dimensional in vitro model; three dimensional in vitro model; dna damage; co-culture in vitro models
Application summary
Radiotherapy is one of the main modalities investigated in cancer research. It has been shown that the incorporation of radiosensitizing agents into cancer cells can further enhance the radiation dose. This has resulted in an increase in tumor cell killing. Our previous work showed that gold nanoparticles (GNPs) can be used as a radiosensitizing agent. Radiation consists of photons, and these photons can produce a shower of secondary electrons in the presence of GNPs since gold has a high atomic number. These secondary electrons can interact with water molecules (which is over 70% in our cell) and produce free radicals that can damage DNA, which could lead to cell death. In this proposed program, we are testing a combination of two radiosensitizing agents, paclitaxel and GNPs. This combination is unique since radiosensitizing agent paclitaxel can block the cell cycle in a phase (G2/M), which is most sensitive to radiation, and GNPs can act as a physical radiosensitizing agent.
We will investigate the radiation dose enhancement in cancer cells when the agents are simultaneously co-delivered versus co-incubated using both lower (keV) and higher (MeV) energy photons. For co-delivery of agents, we will use GNPs as a carrier for paclitaxel. GNPs are being used as drug delivery vehicles because of their biocompatibility and easiness in conjugating other molecules onto its surface. We will use two- and three-dimensional monoculture and co-culture models to investigate the uptake and transport of GNPs in the presence of paclitaxel to determine the optimum time point for delivery of radiation dose. Once we know the optimum time point, we will deliver radiation doses from 2 to 10 Gy with a linear accelerator (MeV photons) and an IR-192 (keV photons) source. We will evaluate the radiation dose enhancement via cell proliferation assay, clonogenic assay, and DNA double strand breaks assay. We will then perform Monte Carlo Simulations to model our experimental data to further understand the mechanisms of radiosensitization.
We will also engineer co-culture models (vs monoculture with one cell type) since they would have features of a real tumor microenvironment with other cell components. For example, cancer associated fibroblast cells (CAFs) promote cancer cell growth, and we want to investigate whether our proposed technology (GNPs, PTX, and radiation) silences those CAFs in a way that they cannot promote cancer cell growth. Such outcomes are critical in bringing this technology to clinic in the future. Our proposed technology and these models together will also pave the way for better cancer therapeutics in the future.
This proposed research program will a) provide a better strategy to enhance radiosensitization, b) provide a full understanding behind the mechanisms of actions using experiments and theory, and c) engineer better 2D and 3D models for testing novel therapeutics.